Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sergio Rutella"'
Autor:
Alan Graham Pockley, James O. Lindsay, Gemma A. Foulds, Sergio Rutella, John G. Gribben, Tobias Alexander, John A. Snowden
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Patients with treatment refractory Crohn’s disease (CD) suffer debilitating symptoms, poor quality of life, and reduced work productivity. Surgery to resect inflamed and fibrotic intestine may mandate creation of a stoma and is often declined by pa
Externí odkaz:
https://doaj.org/article/e11e5aa1746c4a4ca5ec8febd2272d23
Publikováno v:
Journal of Leukocyte Biology. 94:1141-1157
The identification of an anti-tumor effect displayed by cells of innate immunity has opened new scenarios, not only in the field of allo-HSCT but also for nontransplanted patients with hematological malignancies or solid tumors. Donor-derived NK cell
Autor:
Nicola Pirozzi, Alice Bertaina, Sergio Rutella, Ezio Giorda, Matteo Di Nardo, Letizia Pomponia Brescia, Stefano Ceccarelli, Corrado Cecchetti, Antonio Amodeo, Franco Locatelli, Giuseppina Li Pira
Publikováno v:
Pediatric Blood & Cancer. 61:376-379
We report on the successful infusion of human adenovirus (HAdV)-specific T cells in a child with congenital amegakaryocytic thrombocytopenia, given T-cell-depleted hematopoietic stem cell transplantation (HSCT) from the HLA-haploidentical mother duri
Publikováno v:
Blood; Vol 120
The most common cause of treatment failure in childhood acute lymphoblastic leukemia (ALL) remains relapse, occurring in ∼ 15%-20% of patients. Survival of relapsed patients can be predicted by site of relapse, length of first complete remission, a
Autor:
Andrea Pession, Sergio Rutella, Arcangelo Prete, Edoardo Lanino, Ottavio Ziino, Franca Fagioli, Giovanna Giorgiani, Chiara Messina, Attilio Rovelli, Claudio Favre, Franco Locatelli, Giuseppe Palumbo, Mimmo Ripaldi, Riccardo Masetti, Marco Zecca, Marta Pillon, Alice Bertaina, Roberto Rondelli
We analyzed the outcome of 243 children with high-risk (HR) AML in first CR1 enrolled in the AIEOP-2002/01 protocol, who were given either allogeneic (ALLO; n=141) or autologous (AUTO; n=102) hematopoietic SCT (HSCT), depending on the availability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c155d5c079a3b5a20c5aadaa663c4ff
http://hdl.handle.net/2108/129937
http://hdl.handle.net/2108/129937
Autor:
Sergio Rutella, Perla Filippini
Publikováno v:
Expert review of clinical immunology. 10(10)
The efficacy of allogeneic hematopoietic stem cell transplantation is counterbalanced by the occurrence of life-threatening immune-mediated complications, such as graft-versus-host disease (GVHD), a multistep disease which is reportedly fatal to appr
Autor:
Simona Sica, Andrea De Luca, Federica Sorà, Giuseppe Leone, Luigi Ortona, Patrizia Chiusolo, Antonella Cingolani, Luca Laurenti, Sergio Rutella, Nicola Piccirillo, Andrea Antinori
Publikováno v:
Experimental Hematology. 30:279-284
Objective To evaluate the safety, feasibility, and efficacy of allogeneic stem cell transplantation (SCT) for acute myelogenous leukemia (AML) in a young female coinfected by HIV and HCV undergoing highly active antiretroviral therapy (HAART). Patien
Autor:
Francesca Di Florio, Corrado Cecchetti, Antonio Amodeo, Sergio Rutella, Matteo Di Nardo, Franco Locatelli, Alice Bertaina
Publikováno v:
Intensive care medicine. 40(10)
Autor:
Peter Rycus, Kenneth Palmer, Alice Bertaina, Sergio Rutella, Daniela Perrotta, Sergio Picardo, Bernhard Holzgraefe, Antonio Amodeo, Matteo Di Nardo, Vincenzo Di Ciommo, Franco Locatelli, Roberto Lorusso, Corrado Cecchetti, Mirko Belliato
Publikováno v:
Intensive care medicine. 40(5)
Autor:
Maria Ester Bernardo, Daniela Pende, Alessandro Moretta, Francesca Moretta, Alice Bertaina, Manuela Testi, Riccardo Masetti, Franco Locatelli, Letizia Pomponia Brescia, Andrea Finocchi, Daria Pagliara, Pietro Merli, Michela Falco, Rupert Handgretinger, Sergio Rutella, Lorenzo Moretta, Rita Carsetti, Caterina Cancrini, Barbarella Lucarelli, Giuseppina Li Pira, Nabil Kabbara
Twenty-three children with nonmalignant disorders received HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) after ex vivo elimination of αβ(+) T cells and CD19(+) B cells. The median number of CD34(+), αβ(+)CD3(+), and B ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a97ff17ec944dd747eff6b36b03afaf
http://hdl.handle.net/11567/767194
http://hdl.handle.net/11567/767194